Diebold Nixdorf, Incorporated (DBD) is a publicly traded Technology sector company. As of May 21, 2026, DBD trades at $71.41 with a market cap of $2.39B and a P/E ratio of 27.98. DBD moved +4.20% today. Year to date, DBD is +9.27%; over the trailing twelve months it is +46.33%. Its 52-week range spans $34.88 to $89.05. Analyst consensus is buy with an average price target of $100.00. Rallies surfaces DBD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Diebold Nixdorf, Incorporated (DBD) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. DBD moved +4.20% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $71.41 |
| Market Cap | $2.39B |
| P/E Ratio | 27.98 |
| EPS | $2.57 |
| Dividend Yield | 0.00% |
| 52-Week High | $89.05 |
| 52-Week Low | $34.88 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $3.81B |
| Net Income | $97.50M |
| Gross Margin | 25.26% |
2 analysts cover DBD: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $100.00.